Intimation regarding letter dispatched to the shareholders whose email IDs are not registered, for AGM Notice, TDS Communication and Annual Report of the Company for FY 2025-26

August 1, 2026 BSE Limited, National Stock Exchange of India Limited, Floor 25, P. J. Towers, Dalal Street, Fort Exchange Plaza, Bandra-Kurla Complex, Mumbai - 400 001 Bandra (E), Mumbai - 400051 Scrip Code: 530019 Symbol: JUBLPHARMA Sub.: Intimation regarding letter dispatched to the Shareholders of the Company for AGM Notice, TDS Communication and Annual Report of the Company for FY 2025-26 Ref: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) Dear Sir/Madam, Pursuant to Regulation 30 of the Listing Regulations, it is hereby informed that in compliance with Regulation 36(1)(b) of the Listing Regulations, the Company has dispatched letters to Shareholders whose e-mail ids are not registered with Company/Registrar and Transfer Agent/ Depository Participants, providing the weblink where the Annual Report for FY 2025-26 and Notice of the 48th Annual General Meeting of the Company along with TDS Communication can be accessed on Company’s website. A copy of the letter is enclosed herewith for your record. Yours Sincerely, For Jubilant Pharmova Limited Naresh Kapoor Company Secretary Encl.: As above Jubilant Pharmova Limited (CIN: L24116UP1978PLC004624) Regd. Office: Bhartiagram, Gajraula, District : Amroha - 244 223 (U.P.) Phone: +91-5924-267437 Email: investors@jubl.com Website: www.jubilantpharmova.com Date: August 1, 2026 Dear Member(s), Subject: Notice of 48th Annual General Meeting (AGM) of Jubilant Pharmova Limited along with TDS Communication and Annual Report for the Financial Year 2025-26 We wish to inform you that the 48th Annual General Meeting ('AGM') of the members of Jubilant Pharmova Limited (‘the Company’) is scheduled to be held on Wednesday, August 26, 2026 at 11:00 A.M. (IST) through Video Conferencing ('VC') facility / Other Audio Visual Means ('OAVM') to transact the business(es) as set out in notice of AGM dated July 16, 2026. In compliance with Regulation 36(1)(a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), electronic copies of the Notice convening the AGM along with Annual Report for FY 2025-26 is being sent via email to all the members, whose email addresses are registered with the Company or with any Depository or with Registrar & Share Transfer Agent (‘RTA’) of the Company. As per the records available with the Company and/or RTA, your email address is not registered against your demat account/Folio No. as on the cut-off date i.e. Friday, July 24, 2026. Accordingly, we are unable to send the copy of the Notice of the AGM along with TDS Communication and Annual Report for the financial year 2025-26 to you electronically. In accordance with Regulation 36(1)(b) of the Listing Regulations, we are sending you this letter to inform you that the Notice and Annual Report for FY 2025–26 can be accessed through the following links/QR code: Particulars Web link Notice https://jubilantpharmova.com/Uploads/image/2980imguf_JubilantPharmova_Notice.pdf Annual https://www.jubilantpharmova.com/Uploads/image/2981imguf_JubilantPharmovaAR2025- Report 26_WebFile_.pdf QR Code Further, you are requested to register / update your email address with the Company at the earliest either through your Depository Participant for shares held in demat form or send a communication to the Company/ RTA for physical shares, in order to receive all the important information and documents electronically from the Company. Detailed information with respect to procedure for e-voting and participation at the AGM, speaker registration, dividend, etc. is contained in the Notice convening the AGM. For any further information in this regard, please reach out to the Company’s Registrar and Share Transfer Agent at rta@alankit.com or Mr. J.K. Singla, Head-Client Servicing, M/s. Alankit Assignments Limited, 205- 208, Anarkali Complex, Jhandewalan Extension, New Delhi-110 055, India or on Telephone No.: 011-42541234 or to the Company at investors@jubl.com. Looking forward to your participation at the AGM and continued support. Yours faithfully, For Jubilant Pharmova Limited Sd/- Naresh Kapoor Company Secretary Membership No. A11782